No significant differences were observed for family history of prostate cancer, prostate volume, total PSA, PSAD, number of cancer-positive cores, maximum % of tumor involvement in a core, GG, or the adverse pathology binary endpoint. This evidence concerns the gene KLK3 and prostate carcinoma.